BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Montgomery D, Anand JP, Griggs NW, Fernandez TJ, Hartman JG, Sánchez-Santiago AA, Pogozheva ID, Traynor JR, Mosberg HI. Novel Dimethyltyrosine-Tetrahydroisoquinoline Peptidomimetics with Aromatic Tetrahydroisoquinoline Substitutions Show in Vitro Kappa and Mu Opioid Receptor Agonism. ACS Chem Neurosci 2019;10:3682-9. [PMID: 31199621 DOI: 10.1021/acschemneuro.9b00250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Lee YS. Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery. Biomolecules 2022;12:1241. [DOI: 10.3390/biom12091241] [Reference Citation Analysis]
2 Bodnar RJ. Endogenous opiates and behavior: 2019. Peptides 2021;141:170547. [PMID: 33831447 DOI: 10.1016/j.peptides.2021.170547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
3 Montgomery D, Anand JP, Baber MA, Twarozynski JJ, Hartman JG, Delong LJ, Traynor JR, Mosberg HI. Structure-Activity Relationships of 7-Substituted Dimethyltyrosine-Tetrahydroisoquinoline Opioid Peptidomimetics. Molecules 2019;24:E4302. [PMID: 31779072 DOI: 10.3390/molecules24234302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]